At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 42 enrolled
Drug / intervention
Dexamethasone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Intra-Arterial Dexamethasone for the Alleviation of Pain and Postembolization Syndrome Following Uterine Artery Embolization
In Brief
A Phase 3 clinical trial evaluating Dexamethasone and Saline for Leiomyoma. Completed, enrolled 42 participants across 1 site.
Detailed Summary
The purpose of this research is to investigate if administration steroids (anti-inflammatory medication) via the uterine arteries during uterine fibroid embolization (A non surgical procedure for treating uterine fibroids by blocking their blood supply) can help reduce the pain, nausea, vomiting, and general feeling of weakness following the procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLeiomyoma
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
202120222023202420252026
First PostedDec 2020
Enrollment StartJan 2021
Primary CompletionDec 2024
TodayJul 2026
First PostedDec 7, 2020
Enrollment StartJan 25, 2021
Primary CompletionDec 4, 2024
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 5.6 years ago
Interventions
Dexamethasonedrug
Dexamethasone delivered to the uterine arterial bed, prior to embolization.
Salinedrug
Saline delivered to the uterine arterial bed, prior to embolization.